结直肠癌生物标志物与表皮生长因子受体单克隆抗体反应之间的关系 - Suppr

Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodies.

作者信息

Hawkes Eliza, Cunningham David

出版信息

J Clin Oncol. 2010 Oct 1;28(28):e529-31; author reply e532-e533. doi: 10.1200/JCO.2010.29.5626. Epub 2010 Aug 2.

DOI:10.1200/JCO.2010.29.5626

PMID:20679615

Abstract

摘要

相似文献

Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodies.

J Clin Oncol. 2010 Oct 1;28(28):e529-31; author reply e532-e533. doi: 10.1200/JCO.2010.29.5626. Epub 2010 Aug 2.

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies.

J Clin Oncol. 2008 Dec 10;26(35):5668-70. doi: 10.1200/JCO.2008.19.5024. Epub 2008 Nov 10.

Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?

Lancet Oncol. 2010 Nov;11(11):1020-1. doi: 10.1016/S1470-2045(10)70211-4.

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61. doi: 10.1016/S0305-7372(10)70021-9.

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

J Clin Oncol. 2009 Dec 10;27(35):5924-30. doi: 10.1200/JCO.2008.21.6796. Epub 2009 Nov 2.

The forest and the trees: pathways and proteins as colorectal cancer biomarkers.

J Clin Oncol. 2009 Dec 10;27(35):5866-7. doi: 10.1200/JCO.2009.24.8013. Epub 2009 Nov 2.

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.

Eur J Cancer. 2010 Jul;46(11):1997-2009. doi: 10.1016/j.ejca.2010.03.036. Epub 2010 Apr 21.

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

Clin Cancer Res. 2011 Jul 15;17(14):4901-14. doi: 10.1158/1078-0432.CCR-10-3137. Epub 2011 Jun 1.

EGFR FISH in colorectal cancer: what is the current reality?

Lancet Oncol. 2008 May;9(5):402-3. doi: 10.1016/S1470-2045(08)70109-8.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

J Clin Oncol. 2008 Dec 10;26(35):5705-12. doi: 10.1200/JCO.2008.18.0786. Epub 2008 Nov 10.

引用本文的文献

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives.

Gastroenterol Res Pract. 2018 Jun 13;2018:2397863. doi: 10.1155/2018/2397863. eCollection 2018.

Upregulation of c-mesenchymal epithelial transition expression and mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.

Exp Ther Med. 2018 May;15(5):4229-4242. doi: 10.3892/etm.2018.5966. Epub 2018 Mar 19.

Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.

Gastroenterol Res Pract. 2018 Jan 31;2018:4585802. doi: 10.1155/2018/4585802. eCollection 2018.

The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care.

Therap Adv Gastroenterol. 2016 Nov;9(6):861-886. doi: 10.1177/1756283X16659790. Epub 2016 Aug 7.

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.

World J Gastroenterol. 2016 Aug 14;22(30):6944-54. doi: 10.3748/wjg.v22.i30.6944.

Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?

Viszeralmedizin. 2015 Dec;31(6):434-9. doi: 10.1159/000442485. Epub 2015 Dec 4.

Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer.

World J Gastroenterol. 2014 Aug 7;20(29):9732-43. doi: 10.3748/wjg.v20.i29.9732.

Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.

Cancer Biol Ther. 2014 May;15(5):623-32. doi: 10.4161/cbt.28179. Epub 2014 Feb 20.

Biomarkers in advanced colorectal cancer: challenges in translating clinical research into practice.

Cancers (Basel). 2011 Apr 1;3(2):1844-60. doi: 10.3390/cancers3021844.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodies.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献